Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +9 more
Jan 27, 2023

Carcinoma, Hepatocellular Trial in Spain (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Elche, Alicante, Spain
  • +26 more
Dec 5, 2022

Carcinoma, Hepatocellular, Colorectal Tumors, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Pembrolizumab, Belzutifan,

Recruiting
  • Carcinoma, Hepatocellular
  • +5 more
  • Duarte, California
  • +39 more
Jul 29, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Carcinoma, Hepatocellular Trial in Worldwide (CC-122, Nivolumab)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +13 more
Apr 16, 2021

Carcinoma, Hepatocellular, Liver Metastases Trial in Esplugues De Llobregat, Terrassa, Barcelona (VORTX Rx treatment)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Liver Metastases
  • VORTX Rx treatment
  • Esplugues De Llobregat, Barcelona, Spain
  • +2 more
Mar 25, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Washington, District of Columbia
  • +57 more
Apr 6, 2021

Carcinoma, Hepatocellular Trial in Worldwide (LY2157299, Sorafenib, Ramucirumab)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Fayetteville, Arkansas
  • +39 more
Dec 21, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Regorafenib (Stivarga, BAY73-4506)
  • Placebo
  • Los Angeles, California
  • +146 more
Aug 11, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Placebo, GC33)

Completed
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +56 more
Apr 1, 2020

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Erlotinib (Tarceva), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • +2 more
  • San Francisco, California
  • +126 more
May 16, 2019

Carcinoma, Hepatocellular Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Nexavar (Sorafenib, BAY43-9006)
  • Placebo
  • Birmingham, Alabama
  • +198 more
Jul 11, 2018

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • La Jolla, California
  • +106 more
Jul 18, 2017

Carcinoma, Hepatocellular Trial in Worldwide (Ablation with the NanoKnife Low Energy Direct Current (LEDC) System)

Completed
  • Carcinoma, Hepatocellular
  • Ablation with the NanoKnife Low Energy Direct Current (LEDC) System
  • Villejuif, Ile-de-France, France
  • +5 more
Nov 7, 2016

Carcinoma, Hepatocellular Trial in Worldwide (BAY73-4506)

Completed
  • Carcinoma, Hepatocellular
  • Regensburg, Bayern, Germany
  • +12 more
Apr 2, 2015

Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Phoenix, Arizona
  • +177 more
Oct 24, 2014

Carcinoma, Hepatocellular Trial in Bondy, Hannover, Barcelona (GV1001)

Completed
  • Carcinoma, Hepatocellular
  • GV1001
  • Bondy, France
  • +2 more
Dec 17, 2008